1
|
IonitaLaza I, Rogers AJ, Lange C, Raby BA
and Lee C: Genetic association analysis of copy-number variation
(CNV) in human disease pathogenesis. Genomics. 93:22–26. 2009.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Welter D, MacArthur J, Morales J, Burdett
T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L and
Parkinson H: The NHGRI GWAS Catalog, a curated resource of
SNP-trait associations. Nucleic Acids Res. 42:(Database Issue).
D1001–D1006. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Inoue K and Lupski JR: Molecular
mechanisms for genomic disorders. Annu Rev Genomics Hum Genet.
3:199–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Stranger BE, Forrest MS, Dunning M, Ingle
CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, et
al: Relative impact of nucleotide and copy number variation on gene
expression phenotypes. Science. 315:848–853. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ambros V: A hierarchy of regulatory genes
controls a larva-to-adult developmental switch in C.
elegans. Cell. 57:49–57. 1989. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lee A, McLean D, Choi J, Kang H, Chang W
and Kim J: Therapeutic implications of microRNAs in pulmonary
arterial hypertension. BMB Rep. 47:311–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kim VN and Nam JW: Genomics of microRNA.
Trends Genet. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Marcinkowska M, Szymanski M, Krzyzosiak WJ
and Kozlowski P: Copy number variation of microRNA genes in the
human genome. BMC Genomics. 12:1832011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cummins JM, He Y, Leary RJ, Pagliarini R,
Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE,
Labourier E, et al: The colorectal microRNAome. Proc Natl Acad Sci
USA. 103:3687–3692. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Das S: Evolutionary origin and genomic
organization of micro-RNA genes in immunoglobulin lambda variable
region gene family. Mol Biol Evol. 26:1179–1189. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu
Z and Zhang M: MicroRNA-650 targets ING4 to promote gastric cancer
tumorigenicity. Biochem Biophys Res Commun. 395:275–280. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Feng L, Xie Y, Zhang H and Wu Y:
Down-regulation of NDRG2 gene expression in human colorectal cancer
involves promoter methylation and microRNA-650. Biochem Biophys Res
Commun. 406:534–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chan E, Patel R, Nallur S, Ratner E,
Bacchiocchi A, Hoyt K, Szpakowski S, Godshalk S, Ariyan S, Sznol M,
et al: MicroRNA signatures differentiate melanoma subtypes. Cell
Cycle. 10:1845–1852. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistance of lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with down-regulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sun B, Pu B, Chu D, Chu X, Li W and Wei D:
MicroRNA-650 expression in glioma is associated with prognosis of
patients. J Neurooncol. 115:375–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mraz M, Dolezalova D, Plevova K, Stano
Kozubik K, Mayerova V, Cerna K, Musilova K, Tichy B, Pavlova S,
Borsky M, et al: MicroRNA-650 expression is influenced by
immunoglobulin gene rearrangement and affects the biology of
chronic lymphocytic leukemia. Blood. 119:2110–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Mathema VB and Koh YS: Inhibitor of
growth-4 mediates chromatin modification and has a suppressive
effect on tumorigenesis and innate immunity. Tumour Biol. 33:1–7.
2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Blanchard F, Duplomb L, Baud'huin M and
Brounais B: The dual role of IL-6-type cytokines on bone remodeling
and bone tumors. Cytokine Growth Factor Rev. 20:19–28. 2009.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Moon S, Jung KS, Kim YJ, Hwang MY, Han K,
Lee JY, Park K and Kim BJ: KGVDB: A population-based genomic map of
CNVs tagged by SNPs in Koreans. Bioinformatics. 29:1481–1483. 2013.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:(Database Issue). D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25
|
DennisSykes CA, Miller WJ and McAleer WJ:
A quantitative Western Blot method for protein measurement. J Biol
Stand. 13:309–314. 1985. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wanet A, Tacheny A, Arnould T and Renard
P: miR-212/132 expression and functions: Within and beyond the
neuronal compartment. Nucleic Acids Res. 40:4742–4753. 2012.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang X, Xu LS, Wang ZQ, Wang KS, Li N,
Cheng ZH, Huang SZ, Wei DZ and Han ZG: ING4 induces G2/M cell cycle
arrest and enhances the chemosensitivity to DNA-damage agents in
HepG2 cells. FEBS Lett. 570:7–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yoon WJ, Heo SJ, Han SC, Lee HJ, Kang GJ,
Yang EJ, Park SS, Kang HK and Yoo ES: Sargachromanol G regulates
the expression of osteoclastogenic factors in human osteoblast-like
MG-63 cells. Food Chem Toxicol. 50:3273–3279. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Li J and Li G: Cell cycle regulator ING4
is a suppressor of melanoma angiogenesis that is regulated by the
metastasis suppressor BRMS1. Cancer Res. 70:10445–10453. 2010.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Garkavtsev I, Kozin SV, Chernova O, Xu L,
Winkler F, Brown E, Barnett GH and Jain RK: The candidate tumour
suppressor protein ING4 regulates brain tumour growth and
angiogenesis. Nature. 428:328–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Stankiewicz P and Lupski JR: Structural
variation in the human genome and its role in disease. Annu Rev
Med. 61:437–455. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wei Q, He W, Lu Y, Yao J and Cao X: Effect
of the tumor suppressor gene ING4 on the proliferation of MCF-7
human breast cancer cells. Oncol Lett. 4:438–442. 2012.PubMed/NCBI
|
33
|
Li J, Martinka M and Li G: Role of ING4 in
human melanoma cell migration, invasion and patient survival.
Carcinogenesis. 29:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lin YM, Chang ZL, Liao YY, Chou MC and
Tang CH: IL-6 promotes ICAM-1 expression and cell motility in human
osteosarcoma. Cancer Lett. 328:135–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Coles AH, Gannon H, Cerny A, KurtJones E
and Jones SN: Inhibitor of growth-4 promotes IkappaB promoter
activation to suppress NF-kappaB signaling and innate immunity.
Proc Natl Acad Sci USA. 107:11423–11428. 2010. View Article : Google Scholar : PubMed/NCBI
|